China Biologic Products, Inc. Contracts & Agreements

PREFERRED SHARES RIGHTS AGREEMENT Dated as of February 22, 2017 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION, as Rights Agent (Filed With SEC on February 23, 2017)

Second Amended andRestated Employment Agreement (Filed With SEC on November 2, 2016)

Settlement Agreement (Summary Translation) (Filed With SEC on August 4, 2016)

Guarantee Agreement (Summary Translation) (Filed With SEC on August 4, 2016)

CONSULTING AGREEMENT (Filed With SEC on August 4, 2016)

Second Amended and Restated Employment Agreement (Filed With SEC on August 4, 2016)

CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE$0.0001 PER SHARE) UNDERWRITING AGREEMENT (Filed With SEC on June 6, 2016)

CHINA BIOLOGIC PRODUCTS, INC. 3,500,000 SHARES OF COMMON STOCK (PARVALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT (Filed With SEC on March 4, 2016)

CHINA BIOLOGIC PRODUCTS, INC. 3,870,000 SHARES OF COMMON STOCK (PARVALUE $0.0001 PER SHARE) AMENDED AND RESTATED UNDERWRITING AGREEMENT (Filed With SEC on March 4, 2016)

CHINA BIOLOGIC PRODUCTS, INC. AMENDED AND RESTATED DIRECTOR AGREEMENT (Filed With SEC on February 25, 2016)

Strategic CooperationAgreement to Source Raw Plasma (Summary translation) (Filed With SEC on September 2, 2015)

CHINA BIOLOGIC PRODUCTS, INC. 3,000,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT (Filed With SEC on June 10, 2015)

Cooperation Agreement on Transfer of SourcePlasma and Plasma Ingredients I+II+III Sediments for Producing BloodProducts (Summary translation) (Filed With SEC on April 16, 2015)

Supplemental Agreementto Cooperation Agreement on Transfer of SourcePlasma and Plasma Ingredients I+II+III Sediments for Producing Blood Products (Summary translation) (Filed With SEC on April 16, 2015)

CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT (Filed With SEC on March 4, 2015)

PREFERRED SHARES RIGHTS AGREEMENT Dated as of January 8, 2015 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION, as Rights Agent (Filed With SEC on January 9, 2015)

CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT (Filed With SEC on November 6, 2014)

Registered Equity PurchaseAgreement (Summary Translation) (Filed With SEC on August 25, 2014)

Equity Exchange Agreement (Summary Translation) (Filed With SEC on August 25, 2014)

Unregistered EquityPurchase Agreement (Summary Translation) (Filed With SEC on August 25, 2014)

CHINA BIOLOGIC PRODUCTS, INC. 1,550,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT (Filed With SEC on June 27, 2014)

Amended and RestatedEmployment Agreement (Filed With SEC on May 15, 2014)

CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT (Filed With SEC on May 8, 2014)

CREDIT AGREEMENT Dated as of February25, 2014 between CHINA BIOLOGIC PRODUCTS,INC. as Borrower, and CHINA MERCHANTS BANKCO., LTD., NEW YORK BRANCH as Lender (Filed With SEC on March 3, 2014)

STANDBY LETTER OF CREDIT (Filed With SEC on March 3, 2014)

Guarantee Agreement (Applicable to Any GuaranteeProvided by Bank) (Filed With SEC on March 3, 2014)

REPURCHASE AGREEMENT (Filed With SEC on February 7, 2014)

REPURCHASE AGREEMENT (Filed With SEC on January 28, 2014)

CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT (Filed With SEC on November 8, 2013)

CREDIT AGREEMENT Dated as of August 8, 2013 between CHINA BIOLOGIC PRODUCTS, INC. as Borrower, and CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH as Lender (Filed With SEC on August 8, 2013)

STANDBY LETTER OF CREDIT (Filed With SEC on August 8, 2013)

Guarantee Agreement (Filed With SEC on August 8, 2013)

REDEMPTION AGREEMENT (Filed With SEC on August 5, 2013)

REGISTRATION RIGHTSAGREEMENT (Filed With SEC on May 17, 2013)

Preferred Shares Rights Agreement, dated as of November 20, 2012 by and between China Biologic Products, Inc. and Securities Transfer Corporation, as rights agent (Filed With SEC on November 21, 2012)

Employment Agreement between Ming Yang and China Biologic Products, Inc., dated August 31, 2012 (Filed With SEC on September 7, 2012)

Employment Agreement between Xiaoying Gao and China Biologic Products, Inc., dated May 11, 2012 (Filed With SEC on May 11, 2012)

Option Grant Agreement between Xiaoying Gao and China Biologic Products, Inc., dated May 11, 2012 (Filed With SEC on May 11, 2012)

Director Agreement, by and between the Company and Yungang Lu, dated March 19, 2012 (Filed With SEC on March 23, 2012)

Indemnity Agreement, by and between the Company and Yungang Lu, dated March 19, 2012 (Filed With SEC on March 23, 2012)

Director Agreement, by and between the Company and David (Xiaoying) Gao, dated October 6, 2011 (Filed With SEC on October 6, 2011)

Indemnity Agreement, by and between the Company and David (Xiaoying) Gao, dated October 6, 2011 (Filed With SEC on October 6, 2011)

Director Agreement, dated as of February 27, 2011, by and between China Biologic Products, Inc. and Dr. Bing Li (Filed With SEC on March 3, 2011)

Indemnification Agreement, dated as of February 27, 2011, by and between China Biologic Products, Inc. and Dr. Bing Li (Filed With SEC on March 3, 2011)

Director Agreement, dated as of February 27, 2011, by and between China Biologic Products, Inc. and Prof. Wenfang Liu (Filed With SEC on March 3, 2011)

Indemnification Agreement, dated as of February 27, 2011, by and between China Biologic Products, Inc. and Prof Wenfang Liu (Filed With SEC on March 3, 2011)

English translation of the Equity Transfer Agreement, dated January 4, 2011, between Logic Management Consulting (China) Co., Ltd. and Shaowen Fan (Filed With SEC on January 10, 2011)

Registration Rights Agreement, dated December 10, 2010, between China Biologic Products, Inc., Warburg Pincus Private Equity X, L.P. and Warburg Pincus X Partners, L.P (Filed With SEC on December 14, 2010)

Employment Agreement, dated December 1, 2010, between China Biologic Products, Inc. and Stanley Lau (Filed With SEC on December 3, 2010)

Equity Transfer Agreement, dated July 8, 2010, by and between Logic Management Consulting (China) Co., Ltd. And Shandong Taibang Biological Products Co., Ltd (Filed With SEC on November 15, 2010)

Independent Director Agreement, dated as of February 4, 2010, by and between China Biologic Products, Inc. and Dr. Xiangmin Cui (Filed With SEC on February 4, 2010)

Indemnification Agreement, dated as of February 4, 2010, by and between China Biologic Products, Inc. and Dr. Xiangmin Cui (Filed With SEC on February 4, 2010)

Form of Registration Rights Agreement (Filed With SEC on June 5, 2009)

Form of 3.8% Convertible Senior Secured Note due 2011 (Filed With SEC on June 5, 2009)

Form of Warrant (Filed With SEC on June 5, 2009)

Form of Securities Purchase Agreement, dated June 5, 2009 (Filed With SEC on June 5, 2009)

Form of Guarantee and Pledge Agreement (Filed With SEC on June 5, 2009)

Form of Indemnification Agreement (Filed With SEC on June 5, 2009)

Supplemental Agreement (English Translation), dated April 18, 2009, between Shandong Taibang Biological Products Co., Ltd. and Fan Qingchun (Filed With SEC on April 23, 2009)

English Translation of the Equity Transfer and Entrustment Agreement, dated April 6, 2009, among Logic Express, Shandong Taibang Biological Products Co., Ltd. and the Shandong... (Filed With SEC on April 13, 2009)

English Translation of the Supplemental Agreement, dated March 31, 2009, among Logic Express, Dalin, and certain shareholders of Dalin (Filed With SEC on April 1, 2009)

English Translation of the Loan Agreement between Shandong Taibang Biological Products Co., Ltd. and Bank Of China, dated January 8, 2009 (Filed With SEC on January 13, 2009)

English Translation of the Amended Equity Transfer Agreement, dated December 12, 2008, among Logic Express, Dalin, and certain shareholders of Dalin (Filed With SEC on December 18, 2008)

English Translation of Second Supplemental Agreement, dated November 14, 2008, among Logic (Filed With SEC on November 20, 2008)

English Translation of Supplemental Agreement, dated November 3, 2008, among Logic Express Limited, Fan Shaowen, as representative of the Dalin shareholders and Dalin (Filed With SEC on November 7, 2008)

English Translation of the China Bank of Communications Loan Contract, dated October 28, 2008, between Shandong Taibang Biological Products Co. Ltd. and Bank of Communications,... (Filed With SEC on November 3, 2008)

Equity Transfer Agreement, between Taibang and the Transferor, dated October 10, 2008 (Filed With SEC on October 16, 2008)

Joint Venture and Cooperation Agreement between the Transferor, between Taibang and Shaanxi Construction, dated September 12, 2008 (Filed With SEC on October 16, 2008)

Agreement on Equity Transfer, Acquisition, Joint Venture and Cooperation, among Taibang, Shaanxi Construction and the Transferor, dated September 12, 2008 (Filed With SEC on October 16, 2008)

Agreement among Taibang, Logic Express and cbio101508exh104.htmBiological Institute, dated September 12, 2008 (Filed With SEC on October 16, 2008)

Equity Transfer Agreement between Logic Express Limited, Dalin and certain shareholders of Dalin, dated September 26, 2008 (Filed With SEC on October 2, 2008)

Form of Independent Director Agreement of China Biologic Products, Inc (Filed With SEC on July 30, 2008)

Form of Indemnity Agreement of China Biologic Products, Inc (Filed With SEC on July 30, 2008)

China Biologic Products, Inc. 2008 Equity Incentive Plan (Filed With SEC on May 13, 2008)

Consulting Agreement, between Stanley Wong and China Biologic Products, Inc., dated May 9, 2008 (Filed With SEC on May 13, 2008)

Employment Agreement, between Y. Tristan Kuo and China Biologic Products, Inc., dated May 9, 2008 (Filed With SEC on May 13, 2008)

Employment Agreement, between Chao Ming Zhao and China Biologic Products, Inc., dated May 9, 2008 (Filed With SEC on May 13, 2008)

Form of Stock Option Award Agreement of China Biologic Products, Inc (Filed With SEC on May 13, 2008)

Category

Industry

Companies

Contracts

China Biologic Products, Inc. Contracts & Agreements